Sat, Sep 20, 2014, 4:58 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • frogsleapmerlot frogsleapmerlot Jun 29, 2005 6:27 PM Flag

    Sold my NBIX

    Gary L. and the Board do not want to sell NBIX at this juncture. They have a pipeline with at least 3 blockbusters including Indiplon. The projected insomnia market just in the good old USA is $5B by FY2010 so plenty of room for Indiplon and Lunesta. Hell, the GNRH molecule could do over $2B in sales and its close to p2 results.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I'm still long NBIX. My holdings at this point are <1 M shares. I'm going to hang on for the future. Indiplon should get the nod for long-term insomnia x-ment. The potential for a buyout is still there but more important NBIX has an intrinsic value far beyond their pps!! While I have more confidence in NFLD, DNDN and GTCB for the near future, <1year, I'm hangin on to the rest for a couple of years.

      Good luck to those who've choosen to remain!! All the best!

      John

 
NBIX
16.02-0.37(-2.26%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.